Eli Lilly plans at least $27 billion in new U.S. manufacturing investments
Economy And Jobs,Manufacturing
From the Left
AllSides Media Bias Rating: Lean Left
Eli Lilly on Wednesday said it will invest at least $27 billion to build four new manufacturing sites in the U.S., as demand for its blockbuster weight loss and diabetes injections soars and the company develops new drugs for other conditions.
It comes as drugmakers and companies across different industries work to build goodwill with President Donald Trump, who has emphasized reshoring manufacturing to the U.S. and reducing reliance on foreign supply chains. Eli Lilly made the announcement at an event in Washington, D.C. — emphasizing the political undertones of the strategy.
Check for Bias
The AI-powered AllSides Bias Checker instantly reveals the bias of a news article. Tap the button to use.
AllSides Picks
Red Blue Translator
State Capitalism
Red Blue Translator
Redistribution of Wealth
Headline Roundup
What Does the Rise of Socialist Candidates Mean for the Democratic Party?
June 25th, 2026
